TCTMD (@TCTMD) header
TCTMD (@TCTMD) profile picture

TCTMD

@TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at https://xitter.gq/t.co/9j3KOiiahQ

 New York, NY
tctmd.com
Joined May 2009
  • Tweets21K
  • Following6.6K
  • Followers28.3K
Early Signs of Vascular, Cardiorespiratory Problems Seen in Regular Vape Users bit.ly/4Bloo52
Image from TCTMD (@TCTMD)
1
511
On-Duty Firefighter Deaths Are Increasingly Cardiac in Nature bit.ly/47HW3s7
Image from TCTMD (@TCTMD)
1
503
Degenerative Mitral Valve Disease Rising Steadily Worldwide With Sharp Sex, Socioeconomic Divides bit.ly/3UBc1Bq
Image from TCTMD (@TCTMD)
1
546
SPYRAL-AFFIRM: Renal Denervation Safe, Effective in Patients Who Are Often Overlooked bit.ly/4sE4zSy
Image from TCTMD (@TCTMD)
3
8
730
Tricuspid Repair Benefits Consistent Across TRIC-I-HF Subgroups bit.ly/48v19It
Image from TCTMD (@TCTMD)
1
6
833
SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO bit.ly/4iUIdJg
SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO

SIMPLAAFY Supports Antithrombotic Monotherapy After LAAO

Accumulating evidence indicates that patients don’t benefit from DAPT after the procedure, Saibal Kar says.

tctmd.com
2
640
As TR Increases in Severity, It Also Becomes More Deadly bit.ly/4kv0VZ4
Image from TCTMD (@TCTMD)
3
628
PROGRESS: TAVI Is Effective, Safe in Moderate AS With At-Risk Features bit.ly/4sEAcv9
Image from TCTMD (@TCTMD)
4
815
Coronary Sinus Reducer Has Little Impact on ANOCA in Sham-Controlled Trial bit.ly/4zpAjxj
Image from TCTMD (@TCTMD)
1
542
That’s a wrap on #TCT2026! You can find all the latest news on TCTMD.com and stay tuned for more coverage coming soon. tctmd.com/TCT2026
483
Want more insights into late-breaking trials from #TCT2026? In this Beyond the Data, Mamas Mamas, Philippe Généreux(@PhilGenereuxMD), and Stephan Windecker discuss the PROGRESS trial outcomes. Watch the full video: bit.ly/47WWnDA
5
6
797
Sirolimus DCB Holds Up Well at 1 Year vs Standard DES in TRANSFORM II bit.ly/4zrTJlj
Image from TCTMD (@TCTMD)
8
13
1,096
Continue learning beyond #TCT2026. Access Impella education, events, and clinical resources: bit.ly/tct2026 #Sponsored
Image from TCTMD (@TCTMD)
3
3
527
CCTA Noninferior to IVUS for PCI Guidance: P4 Trial bit.ly/4jU7JiU
Image from TCTMD (@TCTMD)
1
2
543
TAVI Plus GDMT Suitable for Select Patients With Severe Aortic Regurgitation bit.ly/4edezMF
Image from TCTMD (@TCTMD)
1
490
🔥 Day 3 brought the energy, and #TCT2026 isn’t done yet! From breakthrough science and Live Cases to hands-on learning and unforgettable connections, yesterday delivered moment after moment. 🎥 Relive the highlights, then get ready to make the final day count! 🚀🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @m1chaella_alex @CathWhisperer @caldera_99 @SinaDaneshMD @CAESmedmd @Julio_Farjat @GolzarianH @JyotiJain_MD @Shikha_Cardio @DrBilal_khan @KrutarthKPandya @Shoaib9702 @IoannisSkalidis @Sticchi_Alex @ricosuruagy @ladyheart_md @AnaClaraVi75147 @anast_apost @padideh_daneii @MAnisHaider @Rushil_Vasudev
5
1
7
744
At 1 Year, Real-world Agent DCB Outcomes Reassure Despite Patient Complexity bit.ly/3WkNNMf
Image from TCTMD (@TCTMD)
4
8
794
Closing out an unforgettable #TCT2026 in San Diego! What a fantastic few days of breakthrough science, game-changing innovation, and conversations shaping the future of cardiovascular care. We have been covering it all—for interviews, recaps, findings, and the moments you won’t want to miss, check out TCTMD’s full coverage: tctmd.com/TCT2026
Image from TCTMD (@TCTMD)
2
520
EARLY TAVR: Economic Analysis Supports TAVI Over Clinical Surveillance for Asymptomatic AS bit.ly/3Uhn7eN
Image from TCTMD (@TCTMD)
1
2
4
495
Load more